The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Dendreon Corp  (DNDN) Trade Now »     Rate DNDN  -  Discuss DNDN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
76.0%
Top:
75.0%
Rate DNDN:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

DNDN: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

New Indexes to Track Healthcare Trends and More Graphic_rating_buy DNDN
Mikerun
73%

Below are links and descriptions for 23 new stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking, allows investors to create custom stock portfolios based on their individual preferences, and now features free access to all of the component stocks in each of my indexes. Some of the top performing stocks from my healthcare indexes on a year-to-date basis are highlighted below.

Cosmetic & Restorative Medicine Index: Allergan (NYSE:AGN) (+38%)

<> The <> ...
By  Mike Havrilla   (+1.04%  risk: conservative)  08/04/09 Comment


Access Pharma: A Cancer Biotech Call Option Trade Graphic_rating_buy DNDN
Mikerun
73%
<> The cancer biotech space has attracted the interest of investors, traders, and diversified healthcare giants this year with Johnson & Johnson (NYSE: JNJ) announcing a $1B cash tender offer for Cougar Biotech (NASDAQ: CGRB) last week and Roche's (VTX: ROG) (OTC: RHHBY) mega-deal to acquire full control of Genentech earlier this year. In addition, positive clinical trial results for Dendreon's (NASDAQ: DNDN) Provenge and stock price turnarounds from the brink of zero at Cell Therapeutics (NASDAQ: CTIC) have fueled interest in the small and micro-cap cancer bio-pharma space among investors an...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/27/09 Comment


Bearish on Dendreon Corp Graphic_rating_sell DNDN
67%
           Uptrend on DNDN will not last long, unless actual profit shows up on this stock. High debt-to-equity (over 8 times to equty) and weak balance sheet, consistent negative return on income.  Stay away from this junk.
By  william0509   (+12.74%  risk: aggressive)  05/12/09 1 comment


Updated FDA, Clinical Trial Calendars: CTIC, DNDN, MRX, JNJ, MEDX Graphic_rating_sell DNDN
Mikerun
73%
Below is a summary of updates to the BioMedReports.com database of 241 entries included in the FDA and Clinical Trial Calendars .
 
The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 115 entries through 4/14/09. The FDA Calendar includes the following information: company name, ticker, decision date, and description. 
 
<> <>http://biomedreports.c...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/14/09 Comment


BioMed Stock Movers: DNDN, EXAS, KG Graphic_rating_sell DNDN
Mikerun
73%

Dendreon (DNDN) has stalled out around $6.50 per share after a major rally on news of upcoming presentation at a medical conference later this month. DNDN expects to report Provenge clinical trial results some time before the end of April, although it did not guarantee this would occur at the upcoming presentation.

The recent spike in shares of DNDN and upcoming presentation do not provide any clarity on whether Provenge results will be sufficient for attaining FDA approval and the pending data release will determine the Company's fate.

<> <> <>http://biomedreports.com/article...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/08/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
FRE Freddie Mac
FSLR First Solar Inc.
T AT&T Inc
C Citigroup Inc
DELL Dell Inc
JPM JPMorgan Chase & Co

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on DNDN

Visit streetinsider.com


Discussion Wall + Add  
tanumoy   (+117.03%  risk: conservative)
Upcoming data of an Alzheimer's drug to be presente.. - A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. If the trials data is positive, it...
+   0 replies


More Resources

Graphic_arrow1 About Dendreon Corp - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch